Epigenic Therapeutics logo
Healthcare & Life Sciences

Epigenic Therapeutics

Epigenic Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series B, 2 tracked investors.

activeseries-b
series-b
Stage
2020
Founded
2
Investors

About Epigenic Therapeutics

Epigenic Therapeutics is a company founded in 2020 headquartered in Israel. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Epigenic Therapeutics develops epigenetic gene-modulation therapies using its proprietary EPIREG platform, which applies AI-optimized CRISPR-based components to regulate target gene expression without changing DNA sequence for treatment of human diseases.

Explore Epigenic Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Israel